Open access
Aug 2026
Amyloidogenic Amylin Signaling Links Diabetes to Dementia Pathogenesis
Selective targeting of circulating amyloidogenic amylin and its pathogenic signaling may enable biomarker development and disease-modifying therapies, and enable biomarker development and disease-modifying therapies.
F. Despa, T. Lashley
· TIPS - Trends in Pharmacolog... · 0 citations